Smith Anglin Financial’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,211
| Closed | -$259K | – | 220 |
|
|
2025
Q1 | $259K | Buy |
10,211
+2,418
| +31% | +$61.3K | 0.03% | 171 |
|
|
2024
Q4 | $207K | Sell |
7,793
-14,728
| -65% | -$391K | 0.02% | 201 |
|
|
2024
Q3 | $652K | Buy |
22,521
+495
| +2% | +$14.3K | 0.06% | 99 |
|
|
2024
Q2 | $616K | Buy |
22,026
+1,472
| +7% | +$41.2K | 0.06% | 90 |
|
|
2024
Q1 | $570K | Buy |
20,554
+10,716
| +109% | +$297K | 0.06% | 104 |
|
|
2023
Q4 | $283K | Sell |
9,838
-2,607
| -21% | -$75.1K | 0.03% | 140 |
|
|
2023
Q3 | $413K | Buy |
12,445
+136
| +1% | +$4.51K | 0.05% | 107 |
|
|
2023
Q2 | $451K | Buy |
12,309
+3,343
| +37% | +$123K | 0.05% | 103 |
|
|
2023
Q1 | $366K | Buy |
8,966
+36
| +0.4% | +$1.47K | 0.05% | 108 |
|
|
2022
Q4 | $458K | Sell |
8,930
-582
| -6% | -$29.8K | 0.09% | 87 |
|
|
2022
Q3 | $416K | Sell |
9,512
-24
| -0.3% | -$1.05K | 0.09% | 86 |
|
|
2022
Q2 | $500K | Buy |
9,536
+28
| +0.3% | +$1.47K | 0.15% | 72 |
|
|
2022
Q1 | $492K | Sell |
9,508
-562
| -6% | -$29.1K | 0.11% | 75 |
|
|
2021
Q4 | $595K | Buy |
10,070
+4,794
| +91% | +$283K | 0.1% | 80 |
|
|
2021
Q3 | $227K | Sell |
5,276
-364
| -6% | -$15.7K | 0.04% | 127 |
|
|
2021
Q2 | $221K | Buy |
+5,640
| New | +$221K | 0.04% | 133 |
|
|
2021
Q1 | – | Sell |
-6,193
| Closed | -$228K | – | 143 |
|
|
2020
Q4 | $228K | Buy |
+6,193
| New | +$228K | 0.04% | 122 |
|